|
Product Information |
|
Product name |
Prednisolone |
|
CAS No. |
50-24-8 |
|
Molecular Formula |
C21H28O5 |
|
Molecular Weight |
360.444 |
|
Quality Standard |
97% up by HPLC, EP8/USP38/BP2014 |
|
Appearance |
White powder |
|
COA of Prednisolone |
|
Items |
Specifications |
Results |
|
Appearance |
White or almost white crystalline powder |
White crystalline powder |
|
Identification |
A;B |
Meets test |
|
Specific rotation |
+97°~+103° |
+99° |
|
Chromatogram purity |
Any peak≤1.0% Only one peak>0.50% Total≤2.0% |
Epi-prednisolone<0.05% Hydrocortisone: 0.79% 11-Deoxypredmosolone<0.05% Other detected imputiry: RRT (0.81) 0.06% Total: 0.85% |
|
Loss on drying |
≤0.5% |
0.1% |
|
Residue on ignition |
Negligible |
Negligible |
|
Selenium |
≤0.003% |
<0.003% |
|
Residual solvents |
Methanol≤700ppm Methylene chloride≤600ppm |
29ppm 507ppm |
|
Assay |
97.0~102.0% (on dried substance) |
99.0% |
|
Conclusion |
It conforms to USP38 |
|
|
Micronized |
≤15μm>80%;≤30μm>98% |
|
|
Usage |
Function of Prednisolone
Prednisolone is an adrenal cortex hormone drug. Super-physiological glucocorticoids have a variety of pharmacological effects such as anti-inflammatory, anti-allergic and immune suppression.
1. Anti-inflammatory effects: glucocorticoids reduce and prevent tissue response to inflammation, thereby reducing the performance of inflammation.
2. Immunosuppressive effects: prevent or inhibit cell-mediated immune responses, delayed allergic reactions, reduce the number of T lymphocytes and monocyte eosinophils, reduce the binding ability of immunoglobulins and cell surface receptors, and inhibit interleukins Synthesis and release, thereby reducing the transformation of T cells to lymphoblasts, and reducing the expansion of the primary immune response.
3. Anti-toxic and anti-shock effects: Glucocorticoids can counteract the stimulating response of bacterial endotoxins to the body, reduce cell damage, and play a role in protecting the body.
*Products under the patent are only for R&D use